PD-1 knockout engineered T cells(Guangzhou Anjie Biomedical Technology)(PD-1 knockout engineered T cells(Guangzhou Anjie Biomedical Technology))

概要

基本信息

药物类型

T细胞疗法

别名-

靶点

PD-1

作用机制

PD-1抑制剂(细胞程序性死亡-1抑制剂)

治疗领域

肿瘤呼吸系统疾病

在研适应症-

非在研适应症

晚期非小细胞肺癌

原研机构

广州安捷生物医学技术有限公司

在研机构-

非在研机构

广州安捷生物医学技术有限公司

最高研发阶段无进展临床1/2期

首次获批日期-

最高研发阶段(中国)无进展

特殊审评-

登录后查看时间轴

关联

2

项与 PD-1 knockout engineered T cells(Guangzhou Anjie Biomedical Technology) 相关的临床试验

NCT03706326 / Unknown status临床1/2期IIT

Combination Therapy of Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for Advanced Esophageal Cancer

The study is to assess the safety and efficacy of the immunotherapies using anti-MUC1 CAR T cells and /or PD-1 knockout engineered T cells in the treatment of patients with advanced esophageal cancer.

开始日期2018-09-28

申办/合作机构

广东药科大学

[+1]

NCT03525782 / Unknown status临床1/2期IIT

A Clinical Study of Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for Patients With Advanced Non-small Cell Lung Cancer

The study is to assess the safety and efficacy of the anti-MUC1 CAR T cells and /or PD-1 knockout engineered T cells for patients with advanced non-small cell lung cancer.

开始日期2018-02-01

申办/合作机构

广东药科大学

[+2]

100 项与 PD-1 knockout engineered T cells(Guangzhou Anjie Biomedical Technology) 相关的临床结果

登录后查看更多信息

100 项与 PD-1 knockout engineered T cells(Guangzhou Anjie Biomedical Technology) 相关的转化医学

登录后查看更多信息

100 项与 PD-1 knockout engineered T cells(Guangzhou Anjie Biomedical Technology) 相关的专利（医药）

登录后查看更多信息

100 项与 PD-1 knockout engineered T cells(Guangzhou Anjie Biomedical Technology) 相关的药物交易

登录后查看更多信息